{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:17Z","timestamp":1772165657127,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM088558"],"award-info":[{"award-number":["U54GM088558"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antibiotic use contributes to the rates of sepsis and the associated mortality, particularly through lack of clearance of resistant infections following antibiotic treatment. At the same time, there is limited information on the effects of prescribing of some antibiotics vs. others on subsequent sepsis and sepsis-related mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used a multivariable mixed-effects model to relate state-specific rates of outpatient prescribing overall for oral fluoroquinolones, penicillins, macrolides, and cephalosporins between 2014 and 2015 to state-specific rates of mortality with sepsis (ICD-10 codes A40\u201341 present as either underlying or contributing causes of death on a death certificate) in different age groups of US adults between 2014 and 2015, adjusting for additional covariates and random effects associated with the ten US Health and Human Services (HHS) regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Increase in the rate of prescribing of oral penicillins by 1 annual dose per 1000 state residents was associated with increases in annual rates of mortality with sepsis of 0.95 (95% CI (0.02,1.88)) per 100,000 persons aged 75-84y, and of 2.97 (0.72,5.22) per 100,000 persons aged 85\u2009+\u2009y. Additionally, the percent of individuals aged 50-64y lacking health insurance, as well as the percent of individuals aged 65-84y who are African-American were associated with rates of mortality with sepsis in the corresponding age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest that prescribing of penicillins is associated with rates of mortality with sepsis in older US adults. Those results, as well as the related epidemiological data suggest that replacement of certain antibiotics, particularly penicillins in the treatment of different syndromes should be considered with the aim of reducing the rates of severe outcomes, including mortality related to bacterial infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-4901-7","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T10:02:47Z","timestamp":1582365767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The relation between prescribing of different antibiotics and rates of mortality with sepsis in US adults"],"prefix":"10.1186","volume":"20","author":[{"given":"Edward","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Lipsitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,22]]},"reference":[{"key":"4901_CR1","unstructured":"Elixhauser A, Friedman B, Stranges E. Septicemia in U.S. Hospitals, 2009: Statistical Brief #122. HealthCare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ), 2011. Accessed on Jan. 12, 2019. Available from: https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb122.pdf"},{"key":"4901_CR2","unstructured":"McDermott KW, Elixhauser A, Sun R. Trends in Hospital Inpatient Stays in the United States, 2005\u20132014. Statistical Brief #225. HealthCare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ), 2017. Accessed on Jan. 12, 2019. Available from: https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb225-Inpatient-US-Stays-Trends.pdf"},{"issue":"6","key":"4901_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1532-5415.2012.03989.x","volume":"60","author":"TJ Iwashyna","year":"2012","unstructured":"Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. 2012;60(6):1070\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"4901_CR4","unstructured":"Torio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204. HealthCare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ), 2016. Accessed on Jan. 12, 2019. Available from: https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb204-Most-Expensive-Hospital-Conditions.jsp"},{"key":"4901_CR5","unstructured":"US CDC. Sepsis. Data & Reports (2018). Accessed on Jan. 12, 2019. Available from: https:\/\/www.cdc.gov\/sepsis\/datareports\/index.html"},{"issue":"1","key":"4901_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/cid\/ciu750","volume":"60","author":"C Rhee","year":"2015","unstructured":"Rhee C, Murphy MV, Li L, Platt R, Klompas M. Comparison of trends in Sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis. 2015;60(1):88\u201395.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4901_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jhm.2259","volume":"10","author":"CA Umscheid","year":"2015","unstructured":"Umscheid CA, Betesh J, VanZandbergen C, Hanish A, Tait G, Mikkelsen ME, et al. Development, implementation, and impact of an automated early warning and response system for sepsis. J Hosp Med. 2015;10(1):26\u201331.","journal-title":"J Hosp Med"},{"issue":"2","key":"4901_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1513\/AnnalsATS.201411-498BC","volume":"12","author":"AJ Walkey","year":"2015","unstructured":"Walkey AJ, Lagu T, Lindenauer PK. Trends in sepsis and infection sources in the United States. A population-based study. Ann Am Thorac Soc. 2015;12(2):216\u201320.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"4901_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcrc.2015.09.034","volume":"31","author":"J Stoller","year":"2016","unstructured":"Stoller J, Halpin L, Weis M, Aplin B, Qu W, Georgescu C, et al. Epidemiology of severe sepsis: 2008-2012. J Crit Care. 2016;31(1):58\u201362.","journal-title":"J Crit Care"},{"key":"4901_CR10","unstructured":"US CDC. HealthCare-associated infections (HAIs). (2019). Accessed on Oct 23, 2019. Available from: https:\/\/www.cdc.gov\/winnablebattles\/report\/HAIs.html"},{"issue":"18","key":"4901_CR11","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","volume":"379","author":"SS Magill","year":"2018","unstructured":"Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in prevalence of health care\u2013associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"4901_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1186\/s12889-019-7431-8","volume":"19","author":"E Goldstein","year":"2019","unstructured":"Goldstein E, Olesen SW, Karaca Z, Steiner CA, Viboud C, Lipsitch M. Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states. BMC Public Health. 2019;19(1):1138.","journal-title":"BMC Public Health"},{"key":"4901_CR13","doi-asserted-by":"crossref","unstructured":"Goldstein E, MacFadden DR, Karaca Z, Steiner CA, Viboud C, Lipsitch M. Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states. Int J Antimicrob Agents. 2019; pii: S0924\u20138579(19)30056\u20131.","DOI":"10.1016\/j.ijantimicag.2019.03.004"},{"issue":"11","key":"4901_CR14","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1128\/AAC.00627-10","volume":"54","author":"M Paul","year":"2010","unstructured":"Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851\u201363.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4901_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","volume":"18","author":"MD Zilberberg","year":"2014","unstructured":"Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596.","journal-title":"Crit Care"},{"issue":"20","key":"4901_CR16","doi-asserted-by":"publisher","first-page":"e3694","DOI":"10.1097\/MD.0000000000003694","volume":"95","author":"YC Lee","year":"2016","unstructured":"Lee YC, Hsiao CY, Hung MC, Hung SC, Wang HP, Huang YJ, et al. Bacteremic urinary tract infection caused by multidrug-resistant Enterobacteriaceae are associated with severe Sepsis at admission: implication for empirical therapy. Medicine (Baltimore). 2016;95(20):e3694.","journal-title":"Medicine (Baltimore)"},{"issue":"suppl_3","key":"4901_CR17","doi-asserted-by":"publisher","first-page":"iii2","DOI":"10.1093\/jac\/dky027","volume":"73","author":"PM Hawkey","year":"2018","unstructured":"Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy\/Healthcare Infection Society\/British Infection Association Joint Working Party. J Antimicrob Chemother. 2018;73(suppl_3):iii2\u2013iii78.","journal-title":"J Antimicrob Chemother"},{"key":"4901_CR18","unstructured":"Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR). Report 2017. Accessed on Jan. 12, 2019. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/656611\/ESPAUR_report_2017.pdf"},{"key":"4901_CR19","unstructured":"Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR). Report 2018. Accessed on Jan. 12, 2019. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/759975\/ESPAUR_2018_report.pdf"},{"issue":"10","key":"4901_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S1473-3099(18)30353-0","volume":"18","author":"KD Vihta","year":"2018","unstructured":"Vihta KD, Stoesser N, Llewelyn M, Quan TP, Davies T, Fawcett NJ, et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998\u20132016: a study of electronic health records. Lancet Infect Dis. 2018;18(10):1138\u201349.","journal-title":"Lancet Infect Dis"},{"key":"4901_CR21","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1093\/jac\/dkt212","volume":"68","author":"DM Livermore","year":"2013","unstructured":"Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother. 2013;68:2667\u201374.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4901_CR22","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/jac\/dky031","volume":"73","author":"KB Pouwels","year":"2018","unstructured":"Pouwels KB, Freeman R, Muller-Pebody B, et al. Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association. J Antimicrob Chemother. 2018;73(6):1700\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4901_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijantimicag.2018.08.013","volume":"52","author":"Hannah Lishman","year":"2018","unstructured":"Lishman H, Costelloe C, Hopkins S, et al. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antibiotic resistance: an ecological study. Int J Antimicrob Agents. 2018. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.08.013.","journal-title":"International Journal of Antimicrobial Agents"},{"key":"4901_CR24","doi-asserted-by":"publisher","first-page":"c2096","DOI":"10.1136\/bmj.c2096","volume":"340","author":"C Costelloe","year":"2010","unstructured":"Costelloe C, Metcalf C, Lovering A, et al. Effects of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.","journal-title":"BMJ"},{"issue":"11","key":"4901_CR25","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1128\/AAC.00234-06","volume":"50","author":"M Bergman","year":"2006","unstructured":"Bergman M, Huikko S, Huovinen P, Paakkari P, Sepp\u00e4l\u00e4 H. Finnish study Group for Antimicrobial Resistance (FiRe network). Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2006;50(11):3646\u201350.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4901_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jac\/dkm416","volume":"61","author":"E Tacconelli","year":"2008","unstructured":"Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008;61(1):26\u201338.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"4901_CR27","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1093\/jac\/dks245","volume":"67","author":"GM Knight","year":"2012","unstructured":"Knight GM, Budd EL, Whitney L, Thornley A, Al-Ghusein H, Planche T, et al. Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother. 2012;67(10):2514\u201322.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"4901_CR28","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1128\/AAC.01131-09","volume":"54","author":"KM Wener","year":"2010","unstructured":"Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother. 2010;54(5):2010\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4901_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12916-018-1121-8","volume":"16","author":"GM Knight","year":"2018","unstructured":"Knight GM, Costelloe C, Deeny SR, Moore LSP, Hopkins S, Johnson AP, et al. Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study. BMC Med. 2018;16(1):137.","journal-title":"BMC Med"},{"issue":"1","key":"4901_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/cid\/ciy978","volume":"69","author":"DR MacFadden","year":"2019","unstructured":"MacFadden DR, Fisman DN, Hanage WP, Lipsitch M. The relative impact of community and hospital antibiotic use on the selection of extended-spectrum Beta-lactamase-producing Escherichia coli. Clin Infect Dis. 2019;69(1):182\u20138.","journal-title":"Clin Infect Dis"},{"key":"4901_CR31","unstructured":"US CDC. Antibiotic resistance patient safety atlas. Outpatient Antibiotic Prescription Data. 2019. Available from: https:\/\/gis.cdc.gov\/grasp\/PSA\/indexAU.html. Accessed 12 Jan 2019."},{"key":"4901_CR32","unstructured":"US CDC Wonder. Multiple Cause of Death, 1999-2017 Request. 2019. Available from: https:\/\/wonder.cdc.gov\/mcd-icd10.html. Accessed 5 Jan 2019."},{"key":"4901_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.15585\/mmwr.mm6513a2","volume":"65","author":"L Epstein","year":"2016","unstructured":"Epstein L, Dantes R, Magill S, Fiore A. Varying estimates of Sepsis mortality using death certificates and administrative codes \u2014 United States, 1999\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65:342\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"4901_CR34","doi-asserted-by":"publisher","first-page":"e97714","DOI":"10.1371\/journal.pone.0097714","volume":"9","author":"S Govindan","year":"2014","unstructured":"Govindan S, Shapiro L, Langa KM, Iwashyna TJ. Death certificates underestimate infections as proximal causes of death in the U.S. PLoS One. 2014;9(5):e97714.","journal-title":"PLoS One"},{"key":"4901_CR35","doi-asserted-by":"publisher","first-page":"E04","DOI":"10.5888\/pcd12.140299","volume":"12","author":"P Ong","year":"2015","unstructured":"Ong P, Gambatese M, Begier E, Zimmerman R, Soto A, Madsen A. Effect of cause-of-death training on agreement between hospital discharge diagnoses and cause of death reported, inpatient hospital deaths, New York City, 2008-2010. Prev Chronic Dis. 2015;12:E04.","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"4901_CR36","doi-asserted-by":"publisher","first-page":"e187571","DOI":"10.1001\/jamanetworkopen.2018.7571","volume":"2","author":"C Rhee","year":"2019","unstructured":"Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O'Brien C, et al. Prevalence, underlying causes, and preventability of Sepsis-associated mortality in US acute care hospitals. JAMA Netw Open. 2019;2(2):e187571.","journal-title":"JAMA Netw Open"},{"key":"4901_CR37","unstructured":"US Centers for Disease Control and Prevention. Bridged-Race Population Estimates, 1990\u20132017 data request. 2019. Available from: https:\/\/wonder.cdc.gov\/Bridged-Race-v2017.HTML. Accessed 11 Jan 2019."},{"key":"4901_CR38","unstructured":"United States Census Bureau. American FactFinder. Median Household Income. 2019. Available from: https:\/\/factfinder.census.gov\/faces\/nav\/jsf\/pages\/index.xhtml. Accessed 1 May 2019."},{"key":"4901_CR39","unstructured":"US CDC Wonder. North America Land Data Assimilation System (NLDAS) Daily Air Temperatures and Heat Index (1979-2011) Request. 2018. Available from: https:\/\/wonder.cdc.gov\/nasa-nldas.html. Accessed 1 Dec 2018."},{"key":"4901_CR40","unstructured":"US Census Bureau. Current Population Survey (CPS) (2018). CPS Table Creator. 2019. Available from: https:\/\/www.census.gov\/cps\/data\/cpstablecreator.html. Accessed 1 Feb 2019."},{"key":"4901_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-072X-9-9","volume":"9","author":"HE Wang","year":"2010","unstructured":"Wang HE, Devereaux RS, Yealy DM, Safford MM, Howard G. National variation in United States sepsis mortality: a descriptive study. Int J Health Geogr. 2010;9:9.","journal-title":"Int J Health Geogr"},{"key":"4901_CR42","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41558-018-0161-6","volume":"8","author":"DR MacFadden","year":"2018","unstructured":"MacFadden DR, McGough SF, Fisman D, Santillana M, Brownstein JS. Antibiotic resistance increases with local temperature. Nat Clim Chang. 2018;8:510\u20134.","journal-title":"Nat Clim Chang"},{"key":"4901_CR43","doi-asserted-by":"publisher","unstructured":"McGough SF, MacFadden DR, Hattab MW, M\u00f8lbak K, Santillana M. Rates of increase of antibiotic resistance and ambient temperature in Europe: a cross-national analysis of 28 countries between 2000-2016. BioRxiv 2018. Accessed on Sep. 1, 2019. Available from https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/414920v1.full","DOI":"10.1101\/414920v1.full"},{"key":"4901_CR44","doi-asserted-by":"crossref","unstructured":"Morrill HJ, Morton JB, Caffrey AR, Jiang L, Dosa D, Mermel LA, et al Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System. Antimicrob Agents Chemother. 2017;61(5) pii: e02236\u2013e02216.","DOI":"10.1128\/AAC.02236-16"},{"issue":"12","key":"4901_CR45","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.amjmed.2016.01.048","volume":"129","author":"MP Cheng","year":"2016","unstructured":"Cheng MP, Ren\u00e9 P, Cheng AP, Lee TC. Back to the future: penicillin-susceptible Staphylococcus aureus. Am J Med. 2016;129(12):1331\u20133.","journal-title":"Am J Med"},{"key":"4901_CR46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0169-5347(97)01223-8","volume":"12","author":"F Baquero","year":"1997","unstructured":"Baquero F, Blazquez J. Evolution of antibiotic resistance. Trends Ecol Evol. 1997;12:482\u20137.","journal-title":"Trends Ecol Evol"},{"key":"4901_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1164\/rccm.200703-480OC","volume":"177","author":"AE Barnato","year":"2008","unstructured":"Barnato AE, Alexander SL, Linde-Zwirble WT, Angus DC. Racial variation in the incidence, care, and outcomes or severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med. 2008;177:279\u201384.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"4901_CR48","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1128\/AAC.02505-15","volume":"60","author":"MR Bidell","year":"2016","unstructured":"Bidell MR, Palchak M, Mohr J, Lodise TP. Fluoroquinolone and third-generation-cephalosporin resistance among hospitalized patients with urinary tract infections due to Escherichia coli: do rates vary by hospital characteristics and geographic region? Antimicrob Agents Chemother. 2016;60(5):3170\u20133.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4901_CR49","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.rmed.2013.02.009","volume":"107","author":"K Suresh Babu","year":"2013","unstructured":"Suresh Babu K, Kastelik J, Morjaria JB. Role of long term antibiotics in chronic respiratory diseases. Respir Med. 2013;107(6):800\u201315.","journal-title":"Respir Med"},{"issue":"Suppl 2","key":"4901_CR50","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27\u201372.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4901_CR51","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1164\/rccm.201504-0701ED","volume":"191","author":"MS Niederman","year":"2015","unstructured":"Niederman MS. Macrolide-resistant pneumococcus in community-acquired pneumonia. Is there still a role for macrolide therapy? Am J Respir Crit Care Med. 2015;191(11):1216\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"4901_CR52","doi-asserted-by":"crossref","unstructured":"Feldman C, Richards G. Appropriate antibiotic management of bacterial lower respiratory tract infections. F1000Res. 2018 ;7. pii: F1000 Faculty Rev-1121.","DOI":"10.12688\/f1000research.14226.1"},{"issue":"8","key":"4901_CR53","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1099\/jmm.0.000545","volume":"66","author":"Lauren April Brown","year":"2017","unstructured":"Brown LA, Mitchell AM, Mitchell TJ. Streptococcus pneumoniae and lytic antibiotic therapy: are we adding insult to injury during invasive pneumococcal disease and sepsis? J Med Microbiol. 2017. https:\/\/doi.org\/10.1099\/jmm.0.000545 [Epub ahead of print].","journal-title":"Journal of Medical Microbiology"},{"issue":"1","key":"4901_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3904\/kjim.2014.29.1.27","volume":"29","author":"SH Park","year":"2014","unstructured":"Park SH. Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern. Korean J Intern Med. 2014;29(1):27\u201330.","journal-title":"Korean J Intern Med"},{"key":"4901_CR55","unstructured":"UK Government. Tackling antimicrobial resistance 2019\u20132024: The UK\u2019s five - year national action plan. (2019). Accessed on June 1, 2019. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/784894\/UK_AMR_5_year_national_action_plan.pdf"},{"key":"4901_CR56","unstructured":"US Food and Drug Administration. FDA updates warnings for fluoroquinolone antibiotics. 2016. Accessed on Jan. 11, 2019. Available from: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm513183.htm"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4901-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T21:29:49Z","timestamp":1613856589000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4901-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,22]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4901"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4901-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/527101","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/480137","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,22]]},"assertion":[{"value":"2 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our work is based on publicly available, existing aggregate (state-level) data, with no informed consent from the participants sought, and no approval from ethics committees requested.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Lipsitch reports grants from NIH\/NIGMS, during the conduct of the study; personal fees from Affinivax, personal fees from Merck, grants and personal fees from Pfizer, grants from PATH Vaccine Solutions, outside the submitted work. Edward Goldstein reports no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}